A detailed history of Yhb Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 18,956 shares of BMY stock, worth $1.12 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
18,956
Previous 19,379 2.18%
Holding current value
$1.12 Million
Previous $804,000 21.89%
% of portfolio
0.08%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$39.66 - $51.75 $16,776 - $21,890
-423 Reduced 2.18%
18,956 $980,000
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $75,428 - $99,303
-1,874 Reduced 8.82%
19,379 $804,000
Q1 2024

Aug 14, 2024

BUY
$47.98 - $54.4 $89,914 - $101,945
1,874 Added 9.67%
21,253 $1.15 Million
Q1 2024

Apr 26, 2024

SELL
$47.98 - $54.4 $235,821 - $267,376
-4,915 Reduced 18.78%
21,253 $1.15 Million
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $25,112 - $29,966
-518 Reduced 1.94%
26,168 $1.34 Million
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $5,036 - $5,631
-87 Reduced 0.32%
26,686 $1.55 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $5,606 - $6,225
-88 Reduced 0.33%
26,773 $1.71 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $262 - $298
4 Added 0.01%
26,861 $1.86 Million
Q4 2022

Jan 12, 2023

SELL
$68.48 - $81.09 $17,804 - $21,083
-260 Reduced 0.96%
26,857 $0
Q3 2022

Nov 03, 2022

SELL
$0.13 - $76.84 $25 - $15,060
-196 Reduced 0.72%
27,117 $1.93 Million
Q2 2022

Jul 14, 2022

SELL
$72.62 - $79.98 $14,233 - $15,676
-196 Reduced 0.71%
27,313 $2.1 Million
Q1 2022

Apr 14, 2022

SELL
$61.48 - $73.72 $209,154 - $250,795
-3,402 Reduced 11.01%
27,509 $2.01 Million
Q4 2021

Jan 18, 2022

SELL
$53.63 - $62.52 $113,963 - $132,855
-2,125 Reduced 6.43%
30,911 $1.93 Million
Q3 2021

Oct 28, 2021

SELL
$59.17 - $69.31 $116,328 - $136,263
-1,966 Reduced 5.62%
33,036 $1.96 Million
Q2 2021

Jul 15, 2021

SELL
$61.91 - $67.42 $27,116 - $29,529
-438 Reduced 1.24%
35,002 $2.34 Million
Q1 2021

Apr 22, 2021

SELL
$59.34 - $66.74 $51,863 - $58,330
-874 Reduced 2.41%
35,440 $2.32 Million
Q4 2020

Jan 21, 2021

SELL
$57.74 - $65.43 $137,709 - $156,050
-2,385 Reduced 6.16%
36,314 $2.25 Million
Q3 2020

Nov 02, 2020

SELL
$57.43 - $63.64 $1.83 Million - $2.03 Million
-31,946 Reduced 45.22%
38,699 $2.33 Million
Q2 2020

Jul 20, 2020

SELL
$54.82 - $64.09 $803,990 - $939,943
-14,666 Reduced 17.19%
70,645 $4.15 Million
Q1 2020

Apr 16, 2020

SELL
$46.4 - $67.43 $422,982 - $614,691
-9,116 Reduced 9.65%
85,311 $4.76 Million
Q4 2019

Jan 27, 2020

BUY
$49.21 - $64.19 $1.84 Million - $2.41 Million
37,487 Added 65.84%
94,427 $6.06 Million
Q3 2019

Oct 15, 2019

SELL
$42.77 - $50.71 $16,509 - $19,574
-386 Reduced 0.67%
56,940 $2.89 Million
Q2 2019

Jul 15, 2019

SELL
$44.62 - $49.34 $91,247 - $100,900
-2,045 Reduced 3.44%
57,326 $2.6 Million
Q1 2019

Apr 29, 2019

BUY
$45.12 - $53.8 $69,710 - $83,121
1,545 Added 2.67%
59,371 $2.83 Million
Q4 2018

Jan 11, 2019

BUY
$48.76 - $63.23 $168,709 - $218,775
3,460 Added 6.36%
57,826 $3.01 Million
Q3 2018

Oct 29, 2018

SELL
$55.19 - $62.25 $50,222 - $56,647
-910 Reduced 1.65%
54,366 $3.38 Million
Q2 2018

Jul 09, 2018

SELL
$50.53 - $62.98 $67,204 - $83,763
-1,330 Reduced 2.35%
55,276 $3.06 Million
Q1 2018

Apr 16, 2018

BUY
$59.92 - $68.98 $221,704 - $255,226
3,700 Added 6.99%
56,606 $3.58 Million
Q4 2017

Jan 16, 2018

SELL
$59.94 - $65.35 $1,798 - $1,960
-30 Reduced 0.06%
52,906 $3.24 Million
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $2.92 Million - $3.37 Million
52,936
52,936 $3.37 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Yhb Investment Advisors, Inc. Portfolio

Follow Yhb Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.